CTRI/2020/06/025762暂停3 期
An Open-Label Randomized Controlled, Proof-of-Concept (PoC) Study toEvaluate the Safety and Efficacy of selected Siddha formulations in patientsdiagnosed with COVID-19
试验速览
- 阶段
- 3 期
- 状态
- 暂停
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •ï?· Male, Female and Transgenders.
- •ï?· Age between 18 to 85 years
- •ï?· COVID 19 positive asymptomatic / pre symptomatic, mild and moderately symptomatic patients.
- •ï?· Willing to consent to the study.
排除标准
- •Patients who have received organ transplantation in the past 6 months or planning surgery.Patients with severe or critical covid-19 infections.Patients with any active malignancy. Patients who have severe underlying diseases that affects survival, including blood diseases,dyscrasia, active bleeding, severe malnutrition, etc.
- •Patients with allergic constitution, or patients allergic to investigational products
- •Patients positive for HIV, Hepatitis B and Hepatitis C at screening.Critical patients with life expectancy <48 hours. Septicemia / Multi organ failure Syndrome (MODS).Patients whose ALT/AST levels are 5 times higher than the normal upper limit and total bilirubin is 3 times higher than the upper limit of normal.Patients participating in other COVID 19 trials.
研究者
相似试验
尚未招募
2 期
Safety and efficacy of Siddha formulations viz., Thiriloga Chenduram and Annabedhi chendhuram in the treatment of Veluppu noi (Iron Deficiency Anaemia).CTRI/2022/10/046708Central Council for Research in Siddha Ministry of AYUSH Govt of India Chennai
进行中（未招募）
1 期
A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19.COVID-19MedDRA version: 20.0Level: LLTClassification code 10038700Term: Respiratory infectionSystem Organ Class: 100000004862EUCTR2020-001739-28-BEZLeuven210
进行中（未招募）
1 期
Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney TransplantatioEUCTR2016-001043-39-Outside-EU/EEAF. Hoffmann-La Roche AG720
进行中（未招募）
1 期
A Study of the Safety of Intravenous Brincidofovir for Adenovirus InfectioTreatment of adenovirus infections in adult allogeneic hematopoietic cell transplant recipientsMedDRA version: 20.1 Level: PT Classification code 10060931 Term: Adenovirus infection System Organ Class: 10021881 - Infections and infestationsEUCTR2017-003984-37-ESChimerix, Inc30
进行中（未招募）
1 期
A Study of the Safety of Intravenous Brincidofovir for Adenovirus InfectioTreatment of adenovirus infections in adult allogeneic hematopoietic cell transplant recipientsMedDRA version: 21.1Level: PTClassification code 10060931Term: Adenovirus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2017-003984-37-ITCHIMERIX, INC.30